Abstract
The serine/threonin kinase Aurora A is an oncoprotein, whereas von Hippel-Lindau protein (pVHL) is a tumor suppressor protein. Both proteins have the same localization during mitosis: in the mitotic spindle and the centrosome. These two proteins also have common functions, such as the regulation of the cell cycle, the stability of the mitotic spindle and both intervene in the functioning of centrosomes. In this study we have analyzed the interaction between Aurora A and pVHL with immunoprecipitation and in vitro phosphorylation experiments. We have confirmed that the immunoprecipitation of pVHL from Hek 293 cell extracts were coupled with Aurora A. In addition, the interaction between the two proteins has been tested by analyzing the phosphorylation of pVHL in vitro by Aurora A. The results revealed that pVHL was phosphorylated by Aurora A. In conclusion, the study demonstrated that Aurora A interacts with and phosphorylates pVHL. Given the role of these two proteins in cell division as well as their status in cancer, this interaction requires further investigation.
Similar content being viewed by others
Abbreviations
- APC:
-
anaphase-promoting complex
- GST:
-
glutathione S-transferase, pVHL, von Hippel-Lindau protein
- SDS-PAGE:
-
sodium dodecyl sulphate polyacrylamide gel electrophoresis
References
Ampofo E., Kietzmann T., Zimmer A., Jakupovic M., Montenarh M. & Götz C. 2010. Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1α mediated transcription. Int. J. Biochem. Cell. Biol. 42: 1729–1735.
Carvajal R., Tse A. & Schwartz G. 2006. Aurora kinases: new targets for cancer therapy. Clin. Cancer Res. 12: 6869–6875.
Cowley D.O., Rivera-Perez J.A., Schliekelman M., He Y.J., Oliver T.G., Lu L., O’Quinn R., Salmon E.D., Magnuson T. & Van Dyke T. 2009. Aurora A kinase is essential for bipolar spindle formation and early development. Mol. Cell. Biol. 29: 1059–1071.
Crosio C., Fimia G.M., Loury R., Kimura M., Okano Y., Zhou H., Sen S., Allis C.D. & Sassone-Corsi P. 2002. Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol. Cell. Biol. 22: 874–885.
Ehara H., Yokoi S., Tamaki M., Nishino Y., Takahashi Y., Deguchi T., Kimura M., Yoshioka T. & Okano Y. 2003. Expression of mitotic Aurora/Ipl1p-related kinases in renal cell carcinomas: an immunohistochemical study. Urol. Res. 31: 382–386.
Ferchichi I., Stambouli N., Marrackchi R., Arlot Y., Prigent C., Fadiel A., Odunsi K., Ben Ammar Elgaaied A. & Hamza A. 2010. Experimental and computational studies indicate specific binding of pVHL protein to Aurora A kinase. J. Phys. Chem. B 114: 1486–1497.
Fu J., Bian M., Jiang Q. & Zhang C. 2007. Roles of Aurora kinases in mitosis and tumorigenesis. Mol. Cancer Res. 5: 1–10.
Giet R., McLean D., Descamps S., Lee M.J., Raff J.W., Prigent C. & Glover D.M. 2002. Drosophila Aurora A kinase is required to localize D-TACC to centrosomes and to regulate astral microtubules. J. Cell. Biol. 156: 437–451.
Hergovich A., Lisztwan J., Barry R., Ballschmieter P. & Krek W. 2003. Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. Nat. Cell Biol. 1: 64–70.
Kim W.Y. & Kaelin W.G. 2004. Role of VHL gene mutation in human cancer. J. Clin. Oncol. 22: 4991–5004.
Kuehn E.W., Walz G. & Benzing T. 2007. Von Hippel-Lindau: a tumor suppressor links microtubules to ciliogenesis and cancer development. Cancer Res. 67: 4537–4540.
Loh J.K., Lieu A.S., Chou C.H., Lin F.Y., Wu C.H., Howng S.L., Chio C.C. & Hong Y.R. 2010. Differential expression of centrosomal proteins at different stages of human glioma. BMC Cancer. 10: 268.
Lolkema M.P., Gervais M.L., Snijckers C.M., Hill R.P., Giles R.H., Voest E.E. & Ohh M. 2005. Tumor suppression by the von Hippel-Lindau protein requires phosphorylation of the acidic domain. J. Biol. Chem. 280: 22205–22211.
Lolkema M.P., Mehra N., Jorna A.S., van Beest M., Giles R.H. & Voest E.E. 2004. The von Hippel-Lindau tumor suppressor protein influences microtubule dynamics at the cell periphery. Exp. Cell Res. 301: 139–146.
Marumoto T., Zhang D. & Saya H. 2005. Aurora A — a guardian of poles. Nat. Rev. Cancer. 5: 42–50.
Meraldi P. & Nigg E.A. 2002. The centrosome cycle. FEBS Lett. 521: 9–13.
Nadler Y., Camp R.L., Schwartz C., Rimm D.L., Kluger H.M. & Kluger Y. 2008. Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer. Clin. Cancer Res. 14: 4455–4462.
Roe J.S. & Youn H.D. 2006. The positive regulation of p53 by the tumor suppressor VHL. Cell. Cycle 5: 2054–2056.
Sinha S., Mondal G., Hwang E.J., Han da W., Dutta S.K., Iyer S., Karumanchi S.A., Kim K.I., Couch F.J. & Mukhopadhyay D. 2011. Von Hippel-Lindau gene product directs cytokinesis: a new tumor suppressor function. J. Cell Sci. 124: 2132–2142.
Thoma C.R., Toso A., Gutbrodt K.L., Reggi S.P., Frew I.J., Schraml P., Hergovich A., Moch H., Meraldi P. & Krek W. 2009. VHL loss causes spindle misorientation and chromosome instability. Nat. Cell Biol. 11: 994–1001.
Woodward E.R., Buchberger A., Clifford S.C., Hurst L.D., Affara N.A. & Maher E.R. 2000. Comparative sequence analysis of the VHL tumor suppressor gene. Genomics 65: 253–265.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ferchichi, I., Arlot, Y., Cremet, JY. et al. Aurora A kinase interacts with and phosphorylates VHL protein. Biologia 67, 1026–1030 (2012). https://doi.org/10.2478/s11756-012-0091-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11756-012-0091-0